A community-based study of human immunodeficiency virus type 2 provirus load in a rural village in West Africa

Journal of Infectious Diseases

Volumn 173, Issue 1, 1996, Pages 245-248

  Ariyoshi, K ^a   Berry, N ^b   Wilkins, A ^b   Ricard, D ^b   Aaby, P ^b   Naucler A ^b   Ngom, P T ^b   Jobe, O ^b   Jaffar, S ^b   Dias, F ^b   Tedder, R S ^b   Whittle, H ^b  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALARIA; MORTALITY; PARASITEMIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROVIRUS; RURAL AREA; SYPHILIS; T CELL LEUKEMIA;

EID: 19144364830     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.1.245     Document Type: Article

References (15)

1. De Cock KM, Adjiololo G, Ekpini E, et al. Epidemiology and transmission of HIV-2: why there is no HIV-2 pandemic. JAMA 1993;270: 2083-6.
2. Whittle HC, Wilkins A, Morris J, et al. Patients infected with HIV-2 survive longer than those infected with HIV-1. AIDS 1994;8:1617-20.
3. Marlink R, Kanki P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-I. Science 1994;265: 1587-90.
4. Bjorling E, Scarlatti G, von Gegerfelt A, et al. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. Virology 1993;193:528-30.
5. Ariyoshi K, Cham F, Berry N, et al. HIV-2-specific cytotoxic T lymphocyte activity in relation to proviral load. AIDS 1995;9:555-9.
6. + lymphopaenia in HIV-2-infected individuals. AIDS Res Hum Retroviruses 1994;8:1031-7.
7. Simon F, Matheron S, Tamalet C, et al. Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993;7:1411-7.
8. Wilkins A, Ricard D, Todd J, Whittle H, Dias P, Da Silva AP. The epidemiology of HIV infection in a rural area of Guinea Bissau. AIDS 1993;7:1119-22.
9. Ricard D, Wilkins A, Ngom PT, et al. The effects of HIV-2 infection in a rural area of Guinea Bissau. AIDS 1994;8:977-82.
10. Tuke PW, Carson JA. Differential diagnosis of HTLV-I and HTLV-II infections by restriction enzyme analysis of "nested" PCR products. J Virol Methods 1992;40:163-74.
11. Ferre F, Marchese A, Duffy PC, et al. Quantitation of HIV viral burden by PCR in HIV seropositive navy personnel representing Walter Reed stages 1 to 6. AIDS Res Hum Retroviruses 1992;8:269-75.
12. Bieniasz PD, Ariyoshi K, Bourelly MAD, et al. Variable relationship between proviral DNA load and infectious virus titer in peripheral blood mononuclear cells of HIV-1-infected individuals. AIDS 1993;7: 803-6.
13. Chevret S, Kirstetter M, Mariotti M, Lefrere F, Frottier J, Lefrere JJ. Provirus copy number to predict disease progression in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis 1994;169:882-5.
14. Hartung S, Boller K, Cichutek K, Notley SG, Kurth R. Quantitation of a lentivirus in its natural host: simian immunodeficiency virus in African green monkeys. J Virol 1992;66:2143-9.
15. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.